Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

390 public trials 102 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Non Interventional Post Marketing Programme in Neuroendocrine Tumours

NCT00747786

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • University Hospital of Wales Cardiff, United Kingdom
  • Aintree University Hospital Liverpool, United Kingdom
  • Royal Free Hospital London, United Kingdom
  • St. Bartholomew's Hospital London, United Kingdom
View Trial Details
Completed

Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain

NCT03220087

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Hospital General Univ. de Elche Alicante, Spain
  • ICO Badalona Badalona, Spain
  • Hospital Clínico y Provincial de Barcelona Barcelona, Spain
  • Hospital de Bellvitge Barcelona, Spain
View all 28 locations
View Trial Details
Completed

An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1)

NCT01595009

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Chemnitz, Germany
  • Novartis Investigative Site Erlangen, Germany
View Trial Details
Completed

Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors

NCT02267967

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • the 307 Hospital of People's Liberation Army Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Completed

Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors

NCT02063958

Conditions
Cancer, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Stanford Medicine Stanford, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Center for Cancer Research, National Cancer Institute Bethesda, Maryland, United States
View Trial Details
Completed

Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study

NCT02279602

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Markey Cancer Center, Clinical Research Office Lexington, Kentucky, United States
  • Montefiore The Bronx, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions